Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Corvol

Showing results (201-210 of 637) with videos related to

Pageof 64
Sort By:
Current Hypertension Reports|September 12, 2000
Angiotensinogen variants and human hypertensionX Jeunemaitre, A P Gimenez-Roqueplo, J Célérier, et al.
Munchener Medizinische Wochenschrift (1950)|September 21, 1973
[The treatment of essential hypertension (author's transl)]J Menard, P Corvol, J F Bloch-Laine, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1984
Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassayC Genain, J Bouhnik, D Tewksbury, et al.
Kidney International|February 1, 1984
Osmoregulation and renal effects of vasopressin in normal and mildly hypertensive subjectsM Thibonnier, P Sassano, S Daufresne, et al.
British Medical Journal|May 31, 1980
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytomaG Reach, M Thibonnier, C Chevillard, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1982
Role of angiotensinogen in blood pressure homeostasisJ Gardes, J Bouhnik, E Clauser, et al.
Journal of Cardiovascular Pharmacology|February 1, 1989
Comparison of increase in the enalapril dose and addition of hydrochlorothiazide as second-step treatment of hypertensive patients not controlled by enalapril aloneP Sassano, G Chatellier, E Billaud, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Monoclonal antibodies to human angiotensinogen: development of an ELISA for measurement of hepatocyte cultured cells contentJ Mizrahi, E Coezy, C Auzan, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Definition and consequences of blocking the renin-angiotensin system by converting enzyme inhibition]P Sassano, G Chatellier, E Billaud, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Identification and characterization of neutral endopeptidase in endothelial cells of arterial or venous origin]C Llorens-Cortes, H Huang, J M Gasc, et al.
Pageof 64

Showing results (201-210 of 637) with videos related to

Sort By:
Pageof 64
Current Hypertension Reports|September 12, 2000
Angiotensinogen variants and human hypertensionX Jeunemaitre, A P Gimenez-Roqueplo, J Célérier, et al.
Munchener Medizinische Wochenschrift (1950)|September 21, 1973
[The treatment of essential hypertension (author's transl)]J Menard, P Corvol, J F Bloch-Laine, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1984
Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassayC Genain, J Bouhnik, D Tewksbury, et al.
Kidney International|February 1, 1984
Osmoregulation and renal effects of vasopressin in normal and mildly hypertensive subjectsM Thibonnier, P Sassano, S Daufresne, et al.
British Medical Journal|May 31, 1980
Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytomaG Reach, M Thibonnier, C Chevillard, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1982
Role of angiotensinogen in blood pressure homeostasisJ Gardes, J Bouhnik, E Clauser, et al.
Journal of Cardiovascular Pharmacology|February 1, 1989
Comparison of increase in the enalapril dose and addition of hydrochlorothiazide as second-step treatment of hypertensive patients not controlled by enalapril aloneP Sassano, G Chatellier, E Billaud, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Monoclonal antibodies to human angiotensinogen: development of an ELISA for measurement of hepatocyte cultured cells contentJ Mizrahi, E Coezy, C Auzan, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1987
[Definition and consequences of blocking the renin-angiotensin system by converting enzyme inhibition]P Sassano, G Chatellier, E Billaud, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1992
[Identification and characterization of neutral endopeptidase in endothelial cells of arterial or venous origin]C Llorens-Cortes, H Huang, J M Gasc, et al.
Pageof 64